GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q2 2019
Top Holdings46 positions
THE CIGNA GROUP | 5M | $780.8M | 7.1% | $158.64 | -10.67% | 3 qtrssince 2018-Q4 | Increased 71 |
HCA HEALTHCARE INC | 5M | $682.3M | 6.2% | $117.26 | +9.10% | 3 qtrssince 2018-Q4 | Increased 73 |
IQVIA HLDGS INC | 3.9M | $623M | 5.6% | $113.91 | +41.25% | 3 qtrssince 2018-Q4 | Decreased 0 |
FMC CORP | 7.5M | $620.3M | 5.6% | $52.60 | +31.15% | 3 qtrssince 2018-Q4 | Decreased 0 |
MCKESSON CORP | 4.5M | $605.5M | 5.5% | $105.01 | +22.23% | 3 qtrssince 2018-Q4 | Decreased 0 |
DXC TECHNOLOGY CO | 10.9M | $603.3M | 5.5% | $52.89 | +1.01% | 3 qtrssince 2018-Q4 | Decreased 0 |
HOLOGIC INC | 9.8M | $469.4M | 4.3% | $41.07 | +16.91% | 3 qtrssince 2018-Q4 | Decreased 0 |
TAKEDA PHARMACEUTICAL CO LTD | 26.4M | $467.8M | 4.2% | $19.04 | -12.97% | 2 qtrssince 2019-Q1 | Increased 59 |
HUMANA INC | 1.8M | $466.2M | 4.2% | $250.99 | -0.82% | 3 qtrssince 2018-Q4 | Increased 75 |
FIRST DATA CORP NEW | 13.8M | $372.8M | 3.4% | — | — | 3 qtrssince 2018-Q4 | Decreased 0 |
TENET HEALTHCARE CORP | 17.9M | $370.2M | 3.4% | $17.15 | +20.49% | 3 qtrssince 2018-Q4 | Increased 58 |
LYONDELLBASELL INDUSTRIES N | 4.1M | $355.9M | 3.2% | $54.01 | +4.55% | 3 qtrssince 2018-Q4 | Decreased 0 |
ALPHABET INC | 295,659 | $320.1M | 2.9% | $51.94 | +3.45% | 3 qtrssince 2018-Q4 | Decreased 0 |
DISNEY WALT CO | 1.9M | $262.9M | 2.4% | $124.23 | +8.49% | 2 qtrssince 2019-Q1 | Increased 86 |
ELEVANCE HEALTH INC | 870,817 | $245.8M | 2.2% | $239.14 | +6.59% | 3 qtrssince 2018-Q4 | Decreased 0 |
BAUSCH HEALTH COS INC | 9.7M | $245M | 2.2% | $20.71 | +21.76% | 3 qtrssince 2018-Q4 | Increased 56 |
NXP SEMICONDUCTORS N V | 2.4M | $233.2M | 2.1% | $74.22 | +18.18% | 3 qtrssince 2018-Q4 | Decreased 0 |
UNIVERSAL HLTH SVCS INC | 1.8M | $233M | 2.1% | $113.30 | +11.60% | 3 qtrssince 2018-Q4 | Decreased 0 |
CBS CORP NEW | 4.1M | $207M | 1.9% | — | — | 3 qtrssince 2018-Q4 | Increased 49 |
WILLIAMS COS INC | 7.3M | $205.7M | 1.9% | $14.57 | +34.18% | 3 qtrssince 2018-Q4 | Decreased 0 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $11B across 46 positions as of Q2 2019. Top holdings: CI (7.1%), HCA (6.2%), IQV (5.6%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Added 3 new positions, exited 2, increased 17, trimmed 23. Top move: DIS (INCREASED, conviction 86). Portfolio: $11.0B across 46 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR